Intelligent Bio Solutions announces 1-for-10 reverse stock split effective Dec 15, 2025

INTELLIGENT BIO SOLUTIONS INC.

Reverse split approved by stockholders Oct 16, 2025; ratio set by Board at 1-for-10.
Shares outstanding to reduce from ~9.6M to ~0.96M; authorized shares unchanged at 100M.
No fractional shares; cash in lieu paid based on 5-day VWAP preceding split date.
Trading symbol INBS unchanged; new CUSIP 36151G709; split-adjusted trading starts Dec 16.
Historical net loss per share retroactively adjusted: FY2025 basic EPS becomes $(20.04) from $(2.00).

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

INTELLIGENT BIO SOLUTIONS INC.: Approved amendment to Certificate of Incorporation to effect a 1-for-10 reverse stock split (effective 2025-12-15).

Change: charter amendment
Effective: 2025-12-15

Exact text from the filing

At the annual meeting of stockholders of Intelligent Bio Solutions Inc. (the “Company”) held on October 16, 2025, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”) to effect a reverse stock split at a ratio of not less than 1-for-2 and not more than 1-for-10 at any time within 12 months following the date of such stockholder approval, with the exact ratio to be set within this range by the Company’s Board of Directors (the “Board”) at its sole discretion without further approval or authorization of the Company’s stockholders.

View on SEC.gov

259 governance changes filed in the last 30 days. Browse all governance changes →

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-027534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.